Girindus America, Inc. Appoints Dr. Edward Huber as Director - Analytical Development and Quality Control
Girindus announced the appointment of Dr. Edward Huber as Director - Analytical Development & QC.
Dr. Huber will provide managerial and technical leadership in the areas of analytical development and quality control. He brings to Girindus 30 years of pharmaceutical experience in the area of structural elucidation, separations sciences, and the development and validation of analytical methods for the characterization and control of Active Pharmaceutical Ingredients (API) and finished dosage forms.
Dr. Huber received a BS degree from Xavier University and MS and PhD Degrees in Analytical Chemistry from the University of Cincinnati. Ed has demonstrated leadership qualities in both industry and the chemical community. Dr. Huber has held positions of increasing responsibility in analytical chemistry at Marion Merrell Dow, Hoechst Marion Roussel, Aventis and Patheon. He was most recently Director of Analytical Development within Patheon's Pharmaceutical Development Services group.
Most read news
Topics
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.